DIPG is the only trial which has been "extended". Why did they get the PRV and RPDD for DIPG if the data is going to be poor? Also read between the lines in Matt Dunns interviews- the data sounds like it will exceed expectations.
GBM is due in Nov, they explained that, so that is on track still.
- Forums
- ASX - By Stock
- KZA
- Ann: Trading Halt
Ann: Trading Halt, page-27
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)